FindTrial
Sign In

Study to evaluate muscle mass with a body composition analysis machine in young adults, less than and equal to 40 with first time detected diabetes and changes in muscle mass after 6 month of treatment,include standard diabetic oral drugs.

Prevalence of Sarcopenia in young adults with newly diagnosed type 2 Diabetes and the influence of initial treatment on body composition and muscle health. A hospital based prospective cohort study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/106913
Enrollment
122
Registered
2026-03-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nil: Nil

Sponsors

All India Institute of Medical Sciences, Rajkot, Gujarat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged less than 40 years, newly diagnosed with type 2 Diabetes (HbA1c equal or more than 6.5% or fasting glucose equal or more than 126 mg/dL), no prior diabetes treatment or minimal treatment (less than 1 month), and willing to undergo body composition analysis.

Exclusion criteria

Exclusion criteria: Type 1 diabetes, secondary diabetes, severe comorbidities(like cancer, end-stage renal disease), pregnancy, conditions contraindicating body composition testing or who require insulin therapy.

Design outcomes

Primary

MeasureTime frame
change in skeletal muscle mass and segmental lean mass from baseline to 6 months, measured using InBody 770, Dynamometer in newly diagnosed Diabetes mellitus, Also calculate the prevalence of sarcopenia.Timepoint: Baseline(0 month) and at end of study(6 month)—

Secondary

MeasureTime frame
Association between changes in skeletal muscle mass and glycemic control(HbA1c) over 6 month. prevalence and severity of sarcopenia at baseline and 6 months(using muscle mass, handgrip strength and gait speed). change in phase angle from baseline to 6 months. Change in body composition parameters(body fat%, visceral fat, extracellular water ratio) from baseline to 6 months.Timepoint: Baseline(0 month) and at end of study(6 month)—

Countries

India

Contacts

Public ContactPriyank kumar singh

All india institute of medical sciences, rajkot, gujarat

komal.jangir3@gmail.com8302458006

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026